Participation in high-profile conferences like Citi's and Evercore's can enhance Alvotech's visibility among investors and industry peers. The one-on-one meetings and fire-side chat provide opportunities to showcase their biosimilar medicines and strategic direction, potentially leading to increased investor interest and positive sentiment towards the stock.